Neonatal vein thrombosis in a heterozygous carrier of both factor V Leiden and prothrombin mutations;Thrombose veine use rénale néonatale et double hétérozygotie pour le facteur V Leiden et la prothrombine

Archives de Pediatrie

Volumn 8, Issue 11, 2001, Pages 1222-1225

  Leret, N ^a,c   Cortey, A ^a   Maillard, C ^a   Rouabah, M ^a   Hascoet J M ^a   Lecompte, T ^b   De Maistre, E ^b  

^a Maternite Regionale Universitaire   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c LE HAVRE HOSPITAL   (France)

Author keywords

Genetic factor V Leiden; Genetic prothrombin; Infant, newborn; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5; FIBRINOLYTIC AGENT; PROTHROMBIN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; HEPARIN;

ADRENAL HEMORRHAGE; ARTICLE; CASE REPORT; FIBRINOLYTIC THERAPY; HETEROZYGOSITY; HUMAN; INFERIOR CAVA VEIN; KIDNEY VEIN; NEWBORN; PROGNOSIS; RECURRENT DISEASE; VEIN THROMBOSIS; ADRENAL DISEASE; BLEEDING; GENETICS; MALE; PATHOLOGY; RISK FACTOR;

ADRENAL GLAND DISEASES; ANTICOAGULANTS; CASE REPORT; ENGLISH ABSTRACT; FACTOR V; HEMORRHAGE; HEPARIN; HUMAN; INFANT, NEWBORN; MALE; PROGNOSIS; PROTHROMBIN; RENAL VEINS; RISK FACTORS; THROMBOLYTIC THERAPY; VENA CAVA, INFERIOR; VENOUS THROMBOSIS;

EID: 18044403392     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(01)00639-X     Document Type: Article

References (15)

1. Disorders of hemostasis in childhood: Risk factors for venous thromboembolism
2. Neonatal thrombosis: Report of a prospective Canadian and international registry
3. Neonatal symptomatic thromboembolism in Germany: Two year survey
4. Early neonatal renal venous thrombosis: Long-term outcome
5. Low-molecular-weight heparin in pediatric patients with thrombotic disease: A dose finding study
6. Traitement thrombolytique des thromboses vasculaires du nouveau-né
7. Successful treatment of neonatal arterial thromboses with recombinant tissue plasminogen activator
8. Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates
9. Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease
10. Laboratory screening of inherited thrombotic syndromes
11. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
12. A common genetic variant in the 3rd-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
13. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease
14. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation
15. Antithrombotic therapy in children